GT BIOPHARMA INC (GTBP) Stock Analyst Ratings
NASDAQ:GTBP - Nasdaq - US36254L3087 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to GTBP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.22. This target is 394.27% above the current price.
GTBP was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about GTBP.
In the previous month the buy percentage consensus was at a similar level.
GTBP was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-02 | Roth MKM | Initiate | Buy |
| 2023-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-07 | EF Hutton | Reiterate | Hold -> Hold |
| 2023-06-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-16 | EF Hutton | Reiterate | Hold -> Hold |
| 2023-04-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-31 | EF Hutton | Reiterate | Hold |
| 2023-01-05 | EF Hutton | Initiate | Hold |
| 2022-09-13 | HC Wainwright & Co. | Maintains | Buy |
| 2021-05-24 | HC Wainwright & Co. | Initiate | Buy |
| 2021-04-13 | B. Riley FBR | Initiate | Buy |
| 2021-03-17 | Roth Capital | Initiate | Buy |